Inside Innovation

Bristol Myers Squibb announced that it will commit $300 million over the next five years to tackle racial health disparities and accelerate its diversity and

Life Science Washington announced the launch of its new campaign, “Find Your Best Life in Washington,” to encourage top talent nationwide to learn more about

Chinook Therapeutics, a Vancouver, B.C. based company with offices in Seattle, raised $106 million in advance of an upcoming reverse merger with Berkeley, California-based Aduro

Seattle-based Sana Biotechnology and Silverback Therapeutics are among the 21 biotech startups that 12 top biotech venture capital investors are eyeing for investment opportunities in

Microsoft and its Seattle-based neighbor Adaptive Biotechnologies have been in partnership since 2018 on immuno-sequencing advancements. Now, they’re pivoting their work to collaborate on COVID-19

Adaptive Biotechnologies received FDA clearance for the clonoSEQ® Assay, used to assess the minimal residual disease in a chronic lymphocytic leukemia patient’s blood. Previously, the

Boston-based biotech startup GentiBio has secured licensing deals with Seattle Children’s Research Institute and Benaroya Research Institute at Virginia Mason. The technology from both Seattle-based

Adaptive Biotechnologies is continuing with its plans to move into a 100,000-square-foot headquarters. The new facility, slated to open next year, will allow Adaptive to

Cellular therapy company Lyell Immunopharma is investing $50 million in a new 70,000 square foot manufacturing facility located in Bothell, Washington. This investment will support

CorneaGen, a Seattle-based provider of corneal transplant tissue, committed to donating $100,000 to help fund corneal transplant surgeries for underprivileged people of color in need

The University of Washington and Seattle-based HDT Bio Corp. announced the development of a promising COVID-19 vaccine candidate that uses a cutting-edge approach. Based on

Seattle-based biotech research startup A-Alpha Bio has received an $800,000 grant from the Bill & Melinda Gates Foundation that will support drug research for treating